A study conducted on animals has shown that a covid vaccine developed to be administered orally not only protects fighting against the coronavirus, but also reduces the airborne dissemination of the SARS-CoV-2 virus to the others in close contact, reported by PTI.
The study published in the journal Science Translational Medicine, shows that the vaccine has the capacity to neutralise the virus through mucosal tissue, limiting the infections and the spread of the active airborne particles.
Also read | Study finds Omicron variant of Covid is as severe as Delta variant
In the study, which used hamsters for trials, the vaccine induced a strong antibody response in the blood and lungs.